CapsoVision Reports First Quarter 2026 Financial Results
CapsoVision reported Q1 2026 revenue of $2.8 million, effectively flat year-over-year, driven by a 3% decline in capsule volume offset by a slight increase in average selling price. Gross margin contracted to 48% from 54% due to U.S. trade policy impacts, while operating expenses rose 22% to $8.4 million, primarily from R&D for new CMOS sensors and clinical trials.
Key figures
- Revenue
- 2792000
- Revenue Yoy
- 0%
- Net loss
- 7033000
- Gross margin
- 48%
- Gross profit
- 1329000
- Operating loss
- 7093000
- Weighted avg shares
- 47456908
- Cash and equivalents
- 17933000
- Private placement proceeds
- 14000000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.